Dolutegravir (Tivicay) for HIV infection.
Danielle N. Rhyne is a pharmacy resident at the University of Colorado, Aurora, Colo. Emily S. Byrd is a doctorate of pharmacy candidate at Wingate University, Wingate, N.C. Olga M. Klibanov is an associate professor of pharmacy at Wingate University, Wingate, N.C.
Danielle N
DN
Rhyne
Emily S
ES
Byrd
Olga M
OM
Klibanov
D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006575:Heterocyclic Compounds, 3-Ring / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010078:Oxazines; D010353:Patient Education as Topic; D010879:Piperazines; D017410:Practice Guidelines as Topic; D011728:Pyridones; D000099226:Dolutegravir
D019428:HIV Integrase Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D000099226:Dolutegravir